Impact of the Covid-19 pandemic on perinatal mental health (Riseup-PPD-COVID-19): protocol for an international prospective cohort study.
Anxiety
COVID-19
Coping mechanisms
Depression
Post-traumatic stress disorders
Postpartum
Pregnancy
Risk factors
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
17 02 2021
17 02 2021
Historique:
received:
18
01
2021
accepted:
25
01
2021
entrez:
18
2
2021
pubmed:
19
2
2021
medline:
25
2
2021
Statut:
epublish
Résumé
Corona Virus Disease 19 (COVID-19) is a new pandemic, declared a public health emergency by the World Health Organization, which could have negative consequences for pregnant and postpartum women. The scarce evidence published to date suggests that perinatal mental health has deteriorated since the COVID-19 outbreak. However, the few studies published so far have some limitations, such as a cross-sectional design and the omission of important factors for the understanding of perinatal mental health, including governmental restriction measures and healthcare practices implemented at the maternity hospitals. Within the Riseup-PPD COST Action, a study is underway to assess the impact of COVID-19 in perinatal mental health. The primary objectives are to (1) evaluate changes in perinatal mental health outcomes; and (2) determine the risk and protective factors for perinatal mental health during the COVID-19 pandemic. Additionally, we will compare the results between the countries participating in the study. This is an international prospective cohort study, with a baseline and three follow-up assessments over a six-month period. It is being carried out in 11 European countries (Albania, Bulgaria, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, and the United Kingdom), Argentina, Brazil and Chile. The sample consists of adult pregnant and postpartum women (with infants up to 6 months of age). The assessment includes measures on COVID-19 epidemiology and public health measures (Oxford COVID-19 Government Response Tracker dataset), Coronavirus Perinatal Experiences (COPE questionnaires), psychological distress (BSI-18), depression (EPDS), anxiety (GAD-7) and post-traumatic stress symptoms (PTSD checklist for DSM-V). This study will provide important information for understanding the impact of the COVID-19 pandemic on perinatal mental health and well-being, including the identification of potential risk and protective factors by implementing predictive models using machine learning techniques. The findings will help policymakers develop suitable guidelines and prevention strategies for perinatal mental health and contribute to designing tailored mental health interventions. ClinicalTrials.gov Identifier: NCT04595123 .
Sections du résumé
BACKGROUND
Corona Virus Disease 19 (COVID-19) is a new pandemic, declared a public health emergency by the World Health Organization, which could have negative consequences for pregnant and postpartum women. The scarce evidence published to date suggests that perinatal mental health has deteriorated since the COVID-19 outbreak. However, the few studies published so far have some limitations, such as a cross-sectional design and the omission of important factors for the understanding of perinatal mental health, including governmental restriction measures and healthcare practices implemented at the maternity hospitals. Within the Riseup-PPD COST Action, a study is underway to assess the impact of COVID-19 in perinatal mental health. The primary objectives are to (1) evaluate changes in perinatal mental health outcomes; and (2) determine the risk and protective factors for perinatal mental health during the COVID-19 pandemic. Additionally, we will compare the results between the countries participating in the study.
METHODS
This is an international prospective cohort study, with a baseline and three follow-up assessments over a six-month period. It is being carried out in 11 European countries (Albania, Bulgaria, Cyprus, France, Greece, Israel, Malta, Portugal, Spain, Turkey, and the United Kingdom), Argentina, Brazil and Chile. The sample consists of adult pregnant and postpartum women (with infants up to 6 months of age). The assessment includes measures on COVID-19 epidemiology and public health measures (Oxford COVID-19 Government Response Tracker dataset), Coronavirus Perinatal Experiences (COPE questionnaires), psychological distress (BSI-18), depression (EPDS), anxiety (GAD-7) and post-traumatic stress symptoms (PTSD checklist for DSM-V).
DISCUSSION
This study will provide important information for understanding the impact of the COVID-19 pandemic on perinatal mental health and well-being, including the identification of potential risk and protective factors by implementing predictive models using machine learning techniques. The findings will help policymakers develop suitable guidelines and prevention strategies for perinatal mental health and contribute to designing tailored mental health interventions.
TRIAL REGISTRATION
ClinicalTrials.gov Identifier: NCT04595123 .
Identifiants
pubmed: 33596889
doi: 10.1186/s12889-021-10330-w
pii: 10.1186/s12889-021-10330-w
pmc: PMC7887558
doi:
Banques de données
ClinicalTrials.gov
['NCT04595123']
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
368Subventions
Organisme : European Cooperation in Science and Technology
ID : CA18138
Organisme : Fundação para a Ciência e a Tecnologia
ID : SFRH/BPD/117597/2016
Organisme : Bar-Ilan University (IL)
ID : Re/refu/dango/100
Organisme : Universidade Presbiteriana Mackenzie
ID : CAPES/PROEX
Références
Acta Psychiatr Scand. 2009 May;119(5):350-64
pubmed: 19298573
PLoS One. 2014 Sep 03;9(9):e106370
pubmed: 25184313
BMJ. 2020 Nov 11;371:m4022
pubmed: 33177069
J Clin Med. 2020 Sep 08;9(9):
pubmed: 32911726
Lancet Psychiatry. 2020 Jun;7(6):547-560
pubmed: 32304649
J Affect Disord. 2021 Jan 15;279:1-8
pubmed: 33035748
Methods Inf Med. 2009;48(3):291-8
pubmed: 19387507
BJOG. 2020 Nov;127(12):1548-1556
pubmed: 32633022
Annu Rev Clin Psychol. 2015;11:99-137
pubmed: 25822344
Br J Psychiatry. 2019 Mar;214(3):127-129
pubmed: 30774059
JAMA Psychiatry. 2017 Oct 1;74(10):1021-1029
pubmed: 28877316
J Psychiatr Res. 2018 Sep;104:235-248
pubmed: 30114665
JAMA. 2019 Feb 12;321(6):580-587
pubmed: 30747971
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
J Affect Disord. 2019 May 1;250:363-370
pubmed: 30877859
J Affect Disord. 2020 Sep 1;274:167-173
pubmed: 32469800
Acta Obstet Gynecol Scand. 2020 Jul;99(7):817-818
pubmed: 32374420
Acta Obstet Gynecol Scand. 2012 Nov;91(11):1261-72
pubmed: 22670573
Can J Psychiatry. 2014 Aug;59(8):434-40
pubmed: 25161068
J Affect Disord. 2020 Dec 1;277:5-13
pubmed: 32777604
J Trauma Stress. 2015 Dec;28(6):489-98
pubmed: 26606250
MMWR Morb Mortal Wkly Rep. 2020 Nov 06;69(44):1635-1640
pubmed: 33151917
Am J Obstet Gynecol. 2020 Aug;223(2):293-295
pubmed: 32387321
Perspect Psychiatr Care. 2020 Sep 28;:
pubmed: 32989798
Front Psychiatry. 2018 Feb 01;8:248
pubmed: 29449816
Ann Intern Med. 2015 Jan 6;162(1):55-63
pubmed: 25560714
Rev Esp Quimioter. 2020 Oct;33(5):313-326
pubmed: 32683837
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
J Clin Psychiatry. 2019 Jul 23;80(4):
pubmed: 31347796
Am J Obstet Gynecol. 2015 Feb;212(2):229.e1-7
pubmed: 25218957
PLoS One. 2020 Jun 4;15(6):e0234187
pubmed: 32497090
Lancet Psychiatry. 2020 Jul;7(7):567-568
pubmed: 32502467
J Matern Fetal Neonatal Med. 2020 May 18;:1-7
pubmed: 32419558
PLoS Med. 2007 Oct 16;4(10):e297
pubmed: 17941715
Am J Obstet Gynecol. 2020 Jul;223(1):91.e1-91.e4
pubmed: 32376317